| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.73M | -50,000 | |
| CEO | 2.07M | $8.05M | - | |
| Dir | 1.48M | $5.74M | - | |
| CFO | 1.07M | $4.16M | - | |
| Other | 1.04M | $4.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2022 | Shafique Virani70 | Chief Business Officer | Sale+OE | 10,000 | $10.92 | $109,179.50 | -10.1% | -17.0% | -39.2% | |
| Oct 6, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 38,553 | $11.58 | $446,573.57 | - | -33.3% | -40.0% | |
| Sep 29, 2022 | Tina Marriott Larson73 | President and COO | Sale+OE | 16,000 | $10.86 | $173,748.70 | -7.2% | -33.0% | -28.8% | |
| Sep 15, 2022 | Shafique Virani70 | Chief Business Officer | Sale+OE | 10,000 | $13.36 | $133,634.76 | -9.6% | -30.4% | -34.6% | |
| Sep 1, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 39,066 | $10.35 | $404,199.05 | - | -13.6% | -16.2% | |
| Aug 16, 2022 | Shafique Virani70 | Chief Business Officer | Sale+OE | 30,000 | $12.61 | $378,444.00 | -23.3% | +3.1% | -29.4% | |
| Aug 16, 2022 | Tina Marriott Larson73 | President and COO | Sale+OE | 16,000 | $12.60 | $201,636.80 | -5.1% | +3.1% | -29.4% | |
| Aug 4, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 39,325 | $9.49 | $373,057.57 | - | +7.9% | +29.2% | |
| Jul 7, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 39,614 | $9.05 | $358,647.23 | - | +29.1% | -23.7% | |
| Jun 2, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 42,190 | $6.11 | $257,624.90 | - | +61.9% | +26.8% |